Cutler Group LP Galera Therapeutics, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$1.15 - $2.1 $1,265 - $2,310	-1,100 Reduced 68.75%	500 $0
Q2 2022 Aug 04, 2022	SELL	$1.24 - $2.39 $124 - $239	-100 Reduced 5.88%	1,600 $2,000
Q1 2022 Apr 14, 2022	BUY	$2.01 - $4.19 $200 - $419	100 Added 6.25%	1,700 $4,000
Q4 2021 Jan 18, 2022	BUY	$1.27 - $8.28 $2,032 - $13,247	1,600 New	1,600 $7,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.